Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 113–120 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Aclaris Therapeutics Inc. Zunsemetinib (ATI-450-PsA-201) Psoriatic arthritis Phase 2a Trial Discontinued Oral Immunology: Anti-TNF
Aclaris Therapeutics Inc. ATI-502 (VITI-201 Topical) Vitiligo Phase 2 Trial Discontinued topical N/A
Aclaris Therapeutics Inc. ATI-502 (ATI-50002-AA-201) - dose ranging Alopecia areata Phase 2 Topical Immunology
Aclaris Therapeutics Inc. ATI-502 (VITI-201 Topical) Vitiligo Phase 2 Trial Discontinued topical N/A
Aclaris Therapeutics Inc. ATI-2138 Atopic dermatitis (AD) Phase 2a Data Released Oral Immunology
Aclaris Therapeutics Inc. ATI-502 (ATI-50002-AA-201) - dose ranging Alopecia areata Phase 2 Topical Immunology
Acrivon Therapeutics Inc. ACR-368 Platinum-resistant ovarian,(PROC) endometrial, and urothelial cancers Phase 2b Data Released Intravenous Oncology
Actinium Pharmaceuticals Inc. Actimab-A Solid tumors Phase 2/3 Ongoing Intravenous Oncology